Clearside biomedical Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Clearside biomedical Contact Number

Clearside Biomedical Overview, News & Competitors

1 hours ago Zoominfo.com Show details

(678) 270-3631

Clearside Biomedical’s headquarters are in 900 N Point Pkwy, Ste 200, Alpharetta, Georgia, 30005, United States. What is Clearside Biomedical’s phone number? Clearside Biomedical’s phone number is (678) 270-3631. What is Clearside Biomedical’s stock symbol? Clearside Biomedical’s stock symbol is CLSD. What is Clearside Biomedical’s

Employees: 50
Phone: (678) 270-3631
Location: 900 N Point Pkwy, Ste 200, Alpharetta, 30005, Georgia

Category: Contact NumberShow more

Clearside Biomedical Crunchbase Company Profile & Funding

Just Now Crunchbase.com Show details

Contact Email [email protected] Phone Number (678)270-3631. Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing

Founded: 2011
Founders: Mark Prausnitz, Henry F. Edelhauser

Category: Contact NumberShow more

Tom Godfrey Senior Directo.. Clearside Biomedical

9 hours ago Zoominfo.com Show details

(678) 270-3631

View Tom Godfrey's business profile as Senior Director, Manufacturing at Clearside Biomedical. Find contact's direct phone number, email address, work history, and more.

Occupation: Senior Director, Manufacturing
Location: 900 N Point Pkwy, Ste 200, Alpharetta, 30005, Georgia
Works For: Clearside Biomedical
Phone: (678) 270-3631

Category: Contact NumberShow more

Clearside Biomedical Company Profile Office Locations

7 hours ago Craft.co Show details

Clearside Biomedical has 33 employees at their 1 location and $2.17 M in annual revenue in FY 2019. See insights on Clearside Biomedical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Employees: 33
Type: Public
Founded: 2011
Website: clearsidebio.com

Category: Contact NumberShow more

SEC FORM D/A

4 hours ago Sec.gov Show details

678-428-7570

Principal Place of Business and Contact Information. Name of Issuer; Clearside Biomedical, Inc. Street Address 1 Street Address 2; 212 RIVERGATE DRIVE: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SUWANEE: GEORGIA: 30024: 678-428-7570: 3. Related Persons. Last Name First Name Middle Name; White: Daniel: H. Street Address 1

Category: Contact NumberShow more

SEC FORM D

4 hours ago Sec.gov Show details

678-270-3631

Clearside Biomedical, Inc. Street Address 1 Street Address 2; 900 NORTH POINT PARKWAY: SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; ALPHARETTA: GEORGIA: 30005: 678-270-3631

Category: Contact NumberShow more

SEC FORM D

4 hours ago Sec.gov Show details

678-270-4005

Clearside Biomedical, Inc. Street Address 1 Street Address 2; 1220 Old Alpharetta Rd: Suite 300: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; Alpharetta: GEORGIA: 30005: 678-270-4005

Category: Contact NumberShow more

FORM D SEC

4 hours ago Sec.gov Show details

Clearside Biomedical, Inc. Street Address 1 Street Address 2; 1220 Old Alpharetta Rd. Suite 300: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; Alpharetta: GEORGIA: 30005: 678 …

Category: Contact NumberShow more

Bausch + Lomb and Clearside Biomedical Announce U.S. Fda

2 hours ago Bausch.com Show details

BAUSCH + LOMB AND CLEARSIDE BIOMEDICAL ANNOUNCE U.S. FDA FILING ACCEPTANCE FOR XIPERE™ (TRIAMCINOLONE ACETONIDE SUPRACHOROIDAL INJECTABLE SUSPENSION). PDUFA Action Date Is October 30, 2021. BRIDGEWATER, N.J. and ALPHARETTA, Ga., June 2, 2021 – Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), along with Clearside

Category: Contact NumberShow more

Is Clearside Biomedical Inc. (NASDAQ:CLSD) still hot stock

8 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 57.75 million. CLSD does have institutional investors; and they hold 46.30% of the stock. Clearside Biomedical Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 1 new insider purchases involving 3,000 shares.

Category: Contact NumberShow more

Clearside Biomedical Number of Employees 20152021 CLSD

7 hours ago Macrotrends.net Show details

Clearside Biomedical number of employees from 2015 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Contact AGD Biomedicals Pvt Ltd

1 hours ago Agdbio.com Show details

91-22-2823

AGD Biomedicals (P) Ltd. Mehta Trade Center, No.1 Shivaji Colony, Sir M.V.Road, Andheri East Mumbai – 400 099 INDIA Phone: +91-22-28231061 / 1066 , +91-22-28257999 Fax: +91-22-28224297 Email:[email protected] Name *. First. Last. Email *. Phone *. Select Country *. Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina

Category: Contact SupportShow more

Clearside Biomedical, Inc. (Form: S3, Received: 05/08

3 hours ago Content.edgar-online.com Show details

(678) 270-3631

Clearside Biomedical, Inc. 900 North Point Parkway, Suite 200 . Alpharetta, Georgia 30005 (678) 270-3631 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: Brent B. Siler . Brian F. Leaf . Mark Ballantyne . Cooley LLP . 11951 Freedom Drive . Reston, VA 20190 (703) 456-8000

Category: Contact NumberShow more

Bausch + Lomb and Clearside Biomedical Announce

Just Now Bausch.com Show details

Bausch + Lomb, a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that …

Category: Contact NumberShow more

Clearside Biomedical, Inc. (Form: DEF 14A, Received: 04/26

5 hours ago Content.edgar-online.com Show details

A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 is available without charge upon written request to: Corporate Secretary, Clearside Biomedical, Inc., 900 North Point Parkway, Suite 200, Alpharetta, Georgia 30005.

Category: Contact NumberShow more

Clearside Biomedical Expands XIPERE™ License Agreement

9 hours ago Finance.yahoo.com Show details

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases.

Category: Contact NumberShow more

Clearside Biomedical Inc. (CLSD) At $5.70 Is Well Worth

Just Now Stocksregister.com Show details

Clearside Biomedical Inc. (NASDAQ:CLSD) concluded the trading at $5.70 on Friday, October 01 with a fall of -5.00% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $6.00 and 5Y monthly beta was reading 1.58 with its …

Category: Contact NumberShow more

Clearside Biomedical, Inc. Added to NASDAQ Biotechnology

Just Now Ir.clearsidebio.com Show details

ALPHARETTA, Ga., Dec. 14, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced that it has been selected by NASDAQ for inclusion in the NASDAQ Biotechnology Index® (NBI). The annual re-ranking of the NBI will become effective at …

Category: Tech SupportShow more

What Type Of Shareholders Own The Most Number of Clearside

9 hours ago Finance.yahoo.com Show details

A look at the shareholders of Clearside Biomedical, Inc. (NASDAQ:CLSD) can tell us which group is most powerful.Insiders often own a large chunk of younger, smaller, companies while huge companies

Category: Contact NumberShow more

Clearside Biomedical Announces Positive Safety Results

2 hours ago Finance.yahoo.com Show details

- CLS-AX 0.03 mg dose delivered via suprachoroidal injection was well-tolerated with no treatment related adverse events - - Initiating Cohort 2 patient screening for 0.1 mg dose in June 2021

1. Author: Clearside Biomedical, Inc.

Category: Contact NumberShow more

Clearside Biomedical Establishes Scientific Advisory Board

1 hours ago Ir.clearsidebio.com Show details

ALPHARETTA, Ga., April 09, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today the formation of a Scientific Advisory Board comprised of world-renowned retinal physicians to advise on …

Category: Contact NumberShow more

Thomas Ciulla Net Worth, Biography & Insider Trading History

5 hours ago Insidertrades.com Show details

(678) 270-3631

How do I contact Thomas Ciulla? The corporate mailing address for Dr. Ciulla and other Clearside Biomedical executives is 900 NORTH POINT PARKWAY SUITE 200, ALPHARETTA GA, 30005. Clearside Biomedical can also be reached via phone at (678) 270-3631 and via email at [email protected]

Category: Contact NumberShow more

Clearside Biomedical Funding, Financials, Valuation

9 hours ago Crunchbase.com Show details

Clearside Biomedical has raised a total of $123.9M in funding over 6 rounds. Their latest funding was raised on Jun 7, 2016 from a Undisclosed round. Clearside Biomedical is registered under the ticker NASDAQ:CLSD . Their stock opened with $7.00 in its Jun 2, 2016 IPO. Clearside Biomedical is …

Category: Contact NumberShow more

Clearside Biomedical Expands Patent Portfolio in the U.S

1 hours ago Finance.yahoo.com Show details

The United States Patent and Trademark Office (USPTO) recently granted patent number 10,722,396 to Clearside. This patent covers Clearside’s SCS Microinjector ® for the suprachoroidal

Category: Contact NumberShow more

Clearside Biomedical Archives MassDevice

2 hours ago Massdevice.com Show details

Clearside Biomedical (NSDQ:CLSD) said yesterday that it entered into a license agreement with Bausch Health Ireland (NYSE:BHC) worth …

Category: Contact NumberShow more

Clearside Biomedical, Inc. Announces 50th Patient Enrolled

5 hours ago Ir.clearsidebio.com Show details

Major Milestone for Innovative Ophthalmic Drug Administration Platform. Alpharetta, GA (September 24, 2015) - Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the retina and choroid, today announced the enrollment of the 50 th patient using Clearside’s proprietary ophthalmic drug

Category: Contact NumberShow more

Henry F. Edelhauser Advisor @ LENSAR, Inc. Crunchbase

2 hours ago Crunchbase.com Show details

Number of Current Jobs 3 Number of Past Jobs 3 Henry F. Edelhauser has 3 current jobs including Vice President, Scientific Affairs at Clearside Biomedical , Professor of Ophthalmology at Emory University School of Medicine at Emory University , and Founder at Clearside Biomedical .

Category: Contact NumberShow more

Clearside Biomedical Expands Patent Portfolio in the U.S

5 hours ago Pharmasources.com Show details

Clearside Biomedical announced the recent issuance of three additional patents in the United States and Europe. The United States Patent and Trademark Office (USPTO) recently granted patent number 10,722,396 to Clearside.

Category: Contact NumberShow more

CLSD News Today (Clearside Biomedical) MarketBeat

1 hours ago Marketbeat.com Show details

What Type Of Shareholders Own The Most Number of Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares? finance.yahoo.com - September 14 at 11:34 AM: Clearside Biomedical Expands XIPERE™ License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN Countries au.finance.yahoo.com - September 9 at 7:12 AM

Category: Contact NumberShow more

CLSD Stock Forecast, Price & News (Clearside Biomedical)

6 hours ago Marketbeat.com Show details

(678) 270-3631

How can I contact Clearside Biomedical? Clearside Biomedical's mailing address is 900 NORTH POINT PARKWAY SUITE 200, ALPHARETTA GA, 30005 . The company can be reached via phone at (678) 270-3631 or via email at [email protected] .

Category: Contact NumberShow more

Arctic Vision Announces Expansion of License Territory for

7 hours ago Finance.yahoo.com Show details

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases.

Category: Contact NumberShow more

Clearside Goes All in for CLSTA Ophthalmology

9 hours ago Ois.net Show details

Late last year, when developers of agents that combined anti-platelet derived growth factor with an anti-vascular endothelial growth factor (anti-PDGF/anti-VEGF) to treat wet age-related macular degeneration (AMD) disclosed disappointing trial results, Daniel White, president and CEO of Clearside Biomedical, took notice.. At the time, Clearside had just raised $20 million.

Category: Contact NumberShow more

Clearside Biomedical, Inc. Receives Notice of Allowance

4 hours ago Ir.clearsidebio.com Show details

The Investor Relations website contains information about Clearside Biomedical, Inc.- IR Site's business for stockholders, potential investors, and financial analysts.

Category: Contact NumberShow more

Patents Assigned to Clearside Biomedical, Inc. Justia

Just Now Patents.justia.com Show details

Applicant: CLEARSIDE BIOMEDICAL, INC. Inventors: Ronald YAMAMOTO, Stanley R. CONSTON, David SIERRA. Devices and methods for adjusting the insertion depth of a needle for medicament delivery. Patent number: 10973681. Abstract: An apparatus includes a housing, an adjustment member, and a microneedle.

Category: Contact NumberShow more

Clearside Biomedical : Expands XIPERE™ License Agreement

9 hours ago Marketscreener.com Show details

ALPHARETTA, Ga., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today it has agreed to expand the territories covered by its exclusive license agreement with Arctic Vision, a China …

Category: Contact NumberShow more

Is Clearside Stock a good investment? CLSD Macroaxis

4 hours ago Macroaxis.com Show details

Clearside Biomedi is trading at 6.77 as of the 17th of September 2021, a 4.15% increase since the beginning of the trading day. The stock's lowest day price was 6.29. Get the latest Clearside Biomedi detailed stock quotes, stock trade data, stock price info, and performance analysis, including Clearside Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Clearside Biomedical : Announces Completion of Dosing in

Just Now Marketscreener.com Show details

ALPHARETTA, Ga., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today completion of dosing in Cohort 2 of OASIS, its ongoing Phase 1/2a clinical trial of CLS-AX (axitinib …

Category: Contact NumberShow more

What Do Analysts Say About Clearside Biomedical Inc. (CLSD

5 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 57.75 million. CLSD does have institutional investors; and they hold 46.30% of the stock. Clearside Biomedical Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 1 new insider purchases involving 3,000 shares.

Category: Contact NumberShow more

Christy L. Shaffer General Partner @ Hatteras Venture

1 hours ago Crunchbase.com Show details

Christy L. Shaffer has 2 current jobs as General Partner at Hatteras Venture Partners and Associate Director of Pulmonary and Critical Care Medicine at Burroughs Wellcome. Additionally, Christy L. Shaffer has had 2 past jobs including President ,CEO , Board Member & Consultant at Inspire Pharmaceuticals. Hatteras Venture Partners General Partner.

Category: Contact NumberShow more

CLSD Clearside Biomedical, Inc. Stock Quote

6 hours ago Finviz.com Show details

Thomson Reuters StreetEvents +8.49%. Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial.

Category: Contact NumberShow more

Spark Therapeutics and Clearside Biomedical Announce

4 hours ago Sparktx.com Show details

Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat chronic, blinding diseases of the eye. Clearside’s product candidates focus on diseases affecting the retina and the choroid, especially diseases associated with macular edema.

Category: Contact NumberShow more

Suprachoroidal CLSTA With Intravitreal Aflibercept Versus

7 hours ago Clinicaltrials.gov Show details

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03126786

Category: Contact NumberShow more

Christy L Shaffer General Partner Hatteras Venture

3 hours ago Linkedin.com Show details

I am also active in a number of non-profit organizations which have proven their ability to change lives. Clearside Biomedical Jan 2012 - Present Contact Christy L directly

Title: Partner, Hatteras Venture …
Location: Chapel Hill, North Carolina, United States
1. 500+ connections

Category: Contact NumberShow more

Clsdex1030_500.htm

6 hours ago Sec.gov Show details

CLEARSIDE BIOMEDICAL, INC. August 29, 2019 . (including minutes and official contact reports relating to any communications with any Field in the Territory and (iv) Clearside will notify REGENXBIO of any amendments or supplemental filings relating to Clearside’s device master file number [***] or any other relevant Regulatory Document

Category: Contact NumberShow more

Additional Proxy Soliciting Materials (definitive) (defa14a)

7 hours ago Ih.advfn.com Show details

Clearside Biomedical, Inc. Important Notice Regarding the Availability of Proxy Materials Stockholders Meeting to be held on June 10, 2021 For Stockholders as of record on April 19, 2021 Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions.

Category: Contact NumberShow more

Clearside Biomedical Stock Price Target and Analyst

1 hours ago Pricetargets.com Show details

(678) 270-3631

Clearside Biomedical's physical mailing address is 900 NORTH POINT PARKWAY SUITE 200, ALPHARETTA GA, 30005. The company's listed phone number is (678) 270-3631 and its investor relations email address is [email protected] The official website for Clearside Biomedical is www.clearsidebio.com.

Category: Contact NumberShow more

Analysts Say Clearside Biomedical, Inc. (NASDAQ:CLSD) Can

4 hours ago Marketingsentinel.com Show details

Clearside Biomedical, Inc.’s shares saw a change of 94.89% in year-to-date performance and have moved 9.65% in past 5-day. Clearside Biomedical, Inc. (NASDAQ:CLSD) showed a performance of 70.61% in past 30-days. Number of shares sold short was 1.11 Million shares which calculate 0.37 days to cover the short interests.

Category: Contact NumberShow more

Clsd.merchanttransact.com 109 days left

9 hours ago Site-stats.org Show details

CLSD Stock Price And Chart — NASDAQ:CLSD — TradingView. CLSD-Top Gain: 101%- (Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis)-Potential Short Volumen 8.5M, Float 18.42M, Avg Vol (10 day) 3.07M, Avg Vol (3 month) 426.32k, NasdaqGM, Healthcare-Biotechnology, 1D Red Day Entry …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is the mailing address for clearside biomedical?

Clearside Biomedical's mailing address is 900 NORTH POINT PARKWAY SUITE 200, ALPHARETTA GA, 30005. The company can be reached via phone at 678-270-3631 or via email at [email protected]

What are the analyst ratings for clearside biomedical?

There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Clearside Biomedical stock. View analyst ratings for Clearside Biomedical or view top-rated stocks. What stocks does MarketBeat like better than Clearside Biomedical?

What is the average price target for clearside biomedical?

Their forecasts range from $9.00 to $18.00. On average, they expect Clearside Biomedical's stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 163.7% from the stock's current price. View analysts' price targets for Clearside Biomedical or view top-rated stocks among Wall Street analysts.

What is the ticker symbol for clearside biomedical?

Clearside Biomedical trades on the NASDAQ under the ticker symbol "CLSD.". Clearside Biomedical Inc (NASDAQ:CLSD) announced its quarterly earnings results on Wednesday, August, 7th. Clearside Biomedical is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019.

Brand New Updated

Popular Brands

Costco
Cisco
Ccu
Cae